Recommendations by ASAIO on the selection and treatment of patients with respiratory and circulatory failure associated with COVID-19 using artificial pulmonary and/or cardiac support.
Patients treated with hydroxychloroquine alone or in combination with azithromycin for pneumonia associated with COVID-19 were found to be at increased risk for corrected QT interval prolongation.
Patients who received heart transplants from hepatitis C virus-positive vs -negative donors were found to have comparable survival at 1 year and patients who developed transplant-related hepatitis C responded well to treatment.
